New Endemic Legionella pneumophila Serogroup I Clones, Ontario, Canada by Tijet, Nathalie et al.
The water-borne pathogen Legionella pneumophila 
serogroup 1 (Lp1) is the most commonly reported etiologic 
agent of legionellosis. To examine the genetic diversity, the 
long-term epidemiology, and the molecular evolution of Lp1 
clinical isolates, we conducted sequence-based typing on 
a collection of clinical isolates representing 3 decades of 
culture-conﬁ  rmed legionellosis in Ontario, Canada. Analy-
sis showed that the population of Lp1 in Ontario is highly 
diverse and combines lineages identiﬁ  ed worldwide with lo-
cal strains. Identical types were identiﬁ  ed in sporadic and 
outbreak-associated strains. In the past 15 years, the inci-
dence of some lineages distributed worldwide has tended 
to decrease, and local endemic clones and lineages have 
emerged. Comparative geographic distribution analysis 
suggests that some lineages are speciﬁ  c to eastern North 
America. These ﬁ  ndings have general clinical implications 
for the study of Lp1 molecular evolution and for the identiﬁ  -
cation of Lp1 circulating strains in North America.
L
egionella species are implicated in 2 clinical syn-
dromes: Legionnaires’ disease (LD) and Pontiac fe-
ver, which are collectively known as legionellosis. Pon-
tiac fever is a self-limited, inﬂ  uenza-like illness, whereas 
Legionnaires’ disease is a common cause of serious bac-
terial pneumonia (1,2).
Among the 52 species and 70 serogroups of Legionella 
species (3), L. pneumophila is the major cause of sporadic 
and outbreak legionellosis (91.5%), and serogroup 1 is the 
predominant serotype (84.2%) (4). In industrialized coun-
tries, L. pneumophila is the second most common pathogen 
detected in cases of community-acquired pneumonia that 
requires patient admission to intensive care units (5,6).
During an outbreak or after the detection of sporadic 
cases, appropriate identiﬁ  cation and typing methods are es-
sential for epidemiologic investigations. Adequate typing 
methods are also crucial to determine the degree of related-
ness of bacteria and to enable the reconstruction of micro-
evolutionary events (7). On the basis of analysis of 7 loci, a 
standard sequence-based method for the typing of L. pneu-
mophila serogroup 1 (Lp1) was developed by the European 
Working Group for Legionella Infections (EWGLI) (8,9).
In previous population-based studies, a Legionella 
sequence-based typing (SBT) scheme was used to analyze 
clinical strains either from Europe or with limited time-span 
coverage (10–12). In the present study, we applied SBT to 
examine the genetic diversity, the long-term epidemiology, 
and the molecular evolution of Lp1 clinical isolates using 
a population-based collection that encompassed isolates 
from 30 years of culture-conﬁ  rmed legionellosis cases in 
Ontario.
Methods
Source of Isolates
Legionellosis is a notiﬁ  able disease in Ontario (pop-
ulation 13 million persons). Since 1978, the diagnosis of 
Legionella infections has been centralized at the Ontario 
Public Health Laboratory (OPHL). This laboratory serves 
as the Legionella reference laboratory and performs all 
testing for outbreak investigations and most testing of clin-
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ical specimens. Therefore, isolates analyzed in this study 
are representative of the strains isolated in Ontario in the 
past 3 decades. Information available in the Ontario data-
base includes dates of onset of illness, patient’s age and 
sex, and city and hospital or healthcare facility from which 
specimens were submitted (13). No specimens were sub-
mitted for Legionella isolation from 1978 through 1979. 
From 1980 through 1985, a mean ± SD of 424.1 ± 281.3 
specimens was submitted for isolation every year. From 
1986 through 2007, a mean ± SD of 1,783.5 ± 258.4 speci-
mens was submitted for isolation every year. The mean ± 
SD number of Lp1 culture-conﬁ  rmed cases/year during 
the study period was 7.4 ± 3.5. The proportion of culture-
conﬁ  rmed case-patients with L. pneumophila infection re-
mained stable during the period of analysis, and 66% of the 
isolates were Lp1 (13).
Lung tissues, bronchial-alveolar lavage specimens, 
or sputum specimens were homogenized by using a tissue 
grinder, streaked on buffered charcoal yeast extract agar 
plates and incubated at 37°C (3–7 days). Species and se-
rogroups were conﬁ  rmed by direct immunoﬂ  uorescent an-
tibody assay and slide-agglutination (14,15). Isolates (n = 
217) were stored at –80°C in trypticase soy broth supple-
mented with 5% horse blood. Twenty-three isolates ob-
tained in 1996 and 1997 could not be used and were omit-
ted from our analysis. Outbreaks were deﬁ  ned as >2 cases 
that were submitted from the same hospital or healthcare 
facility or with links to a common source with onset during 
the same 30-day period.
Sequence-based Typing
SBT using loci ﬂ  aA, pilE, asd, mip, mompS, proA, 
and neuA was conducted according to the EWGLI scheme 
(8,9). Automated contig-assembly and base-calling of 
DNA sequence traces were performed by using the EWGLI 
sequence quality tool (16). The sequences obtained from 
this work are available in the EWGLI-SBT database (www.
ewgli.org)
Phylogenetic and Allelic Diversity Analyses
Multiple sequence alignments of concatenated DNA 
sequences and phylogram construction were carried out 
with ClustalW2 (www.ebi.ac.uk/Tools/clustalw2/index.
html) by using the neighbor-joining method with 1,000 
bootstrap replicates (17). Clonal analyses were performed 
by using eBURST3 (http://eBURST.mlst.net) with a group 
deﬁ  nition set to 6 identical alleles and sequence type (ST) 
allelic proﬁ  les were clustered with the unweighted pair 
group method with arithmetic mean (UPGMA) algorithm 
by using splits Tree4 (18). The standardized index of asso-
ciation (IA
S) and the mean genetic diversity were calculated 
with LIAN 3.5 (19).
Ontario Health Regions and Rates Calculations
The 36 public health units of Ontario were aggregat-
ed into 7 health regions (OHRs) with populations rang-
ing from ≈0.5 to 2 million persons: Toronto, South West, 
Central South, Central West, Central East, East, and North. 
Average rates were calculated by dividing disease counts 
by the Statistics Canada population estimates (20,21). OHR 
population estimates were not available before 1995 and 
were estimated from 1990 through 1995 and 2006 through 
2007 by linear extrapolation.
Statistical Analyses and Mapping
Statistical analyses were performed by using STATA 
(StataCorp, College Station, TX, USA). Thematic maps 
were created by using ArcGIS (ESRI, Redlands, CA, 
USA). 
Results
Lp1 Sequence-based Typing
The 194 isolates, collected from 1978 through 2007, 
were resolved into 62 STs (online Appendix Table, www.
cdc.gov/EID/content/16/3/447-appT.htm). Seven STs were 
represented by at least 10 isolates, 13 STs consisted of 
groups containing 2–4 isolates, and 42 STs were repre-
sented by 1 isolate. In comparison to the EWGLI dataset, 
42 STs have only been reported in North America, and 41 
STs are unique to the province of Ontario. The ST with the 
largest number of isolates was ST1 (n = 31). STs previ-
ously reported in the EWGLI database and responsible for 
>9 cases in Ontario include ST36 (n = 10), ST37 (n = 21), 
ST42 (n = 10), and ST62 (n = 16). Two STs, speciﬁ  c to 
the province of Ontario, were detected in >9 legionellosis 
cases: ST211 (n = 15) and ST222 (n = 13). STs resolved 
from outbreak isolates were conﬁ  rmed to be epidemiologi-
cally concordant since related isolates were assigned iden-
tical STs. ST211 strains were obtained from patients in 1 
outbreak (n = 2) in 1993 and from 13 patients with spo-
radic cases. Seven of the 13 ST222 isolates were recovered 
from a legionellosis outbreak at a long-term care facility in 
Ontario in 2005 (10). ST226 was also differentiated from 
strains responsible for a suspected outbreak (n = 2) and is 
speciﬁ  c to Ontario.
Across the 7 loci, 99 alleles were identiﬁ  ed. Three 
new alleles were found, 2 of which (asd 32 and proA 33) 
were identiﬁ  ed in a ST357 strain isolated in 2002 from a 
patient with a sporadic case. The third new allele (mompS 
52) was identiﬁ  ed in a ST358 strain isolated in the South 
West OHR. At the individual loci level, the total number 
of alleles ranged from 10 at ﬂ  aA to 21 at mompS. Because 
the population of Lp1 clinical isolates found in Ontario ap-
peared to be distinct from the isolates reported in the EWG-
LI database, we performed linkage analyses and looked at 
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genetic diversity of our dataset compared to that of the 
EWGLI dataset. Linkage analyses showed that the IA
S for 
the complete dataset was 0.4913. This value is comparable 
with the IA
S of 0.494 in previous studies and suggests link-
age disequilibrium in the dataset obtained from the popula-
tion of clinical Lp1 isolates in Ontario (22). With a value 
of 0.8041 ± 0.0155, the mean ± SD genetic diversity of 
our dataset was similar to the mean genetic diversity of the 
EWGLI dataset.
Phylogenetic Analysis
The population structure of Lp1 clinical isolates from 
Ontario was analyzed by using 62 concatenated sequences 
of 7 loci and compared with results of cluster analysis de-
duced from SBT allelic proﬁ  les. Three major clusters were 
visually identiﬁ  ed from the phylogenetic tree (Figure 1). 
All clusters contain isolates from outbreak and sporadic 
cases. None of the identiﬁ  ed clusters or subgroups were 
exclusively formed with strains identiﬁ  ed with STs spe-
ciﬁ  cally reported in Ontario. This suggests that Ontario 
strains are phylogenetically related to strains found in the 
EWGLI dataset. Phylogenetic cluster I (n = 39) included 
the epidemic strain ST1 and 7 STs of sporadic cases. With 
114 isolates and 46 STs, cluster II was the largest and most 
diverse group from the dataset. In this cluster, Ontario out-
break strains ST37 and ST211 were subgrouped with ST36 
(Philadelphia strain). Cluster III comprised 8 STs and 41 
isolates. With the exception of ST222 (n = 13), none of the 
STs grouped in this cluster were reported to be outbreak 
strains.
Next, the UPGMA algorithm was used to construct a 
dendrogram based on a matrix of pairwise allelic differences 
between the 62 STs of our dataset (Figure 2). The topology 
of the UPGMA dendrogram was partially congruent with 
the neighbor-joining tree based on allelic sequences. The 
UPGMA dendrogram contains 3 major clusters of related 
STs arbitrarily named A, B, and C (Figure 2). Cluster B 
contains all isolates of cluster II except ST210 and ST199, 
which grouped with cluster C. In contrast, STs found in 
clusters I and III were separated into clusters A and C. ST1 
and ST52 clustered in a separate branch at the base of the 
dendrogram, (Figure 2), which suggests that they could be 
phylogenetically distant from other STs. However, this di-
vergence was not observed with the neighbor-joining meth-
od. Based on this ﬁ  nding, for the rest of the analysis, we 
considered cluster II as a well-deﬁ  ned phylogenetic group 
and clusters I/III were analyzed as a single group.
Identiﬁ  cation of Clonal Lineages
The eBURST clonal analysis of our strains showed that 
the province of Ontario presents a semiclonal population 
with 27 single isolates and 11 clonal groups (CGs) (Figure 
2). With 54 isolates and 10 STs, CG1 was the clonal group 
with the largest number of isolates and STs. This clonal 
group (27.8% of Ontario isolates) contained STs that were 
reported elsewhere (ST36, ST37, and ST104) but also STs 
that were unique to Ontario (ST193, ST195, ST196, ST197, 
ST211, and ST229). The founder of CG1 was predicted to 
be ST36 (bootstrap conﬁ  dence [BC] = 68%), and the pre-
dominant single locus variant of this group was ST37 (n = 
21). Members of CG1 were recovered from both sporadic 
and outbreak cases. CG2 (n = 7) only contained isolates 
with STs that are unique to Ontario and the ancestor of this 
group was predicted to be ST209 (BC = 28%). All isolates 
of CG2 were obtained from sporadic cases. Other clonal 
groups unique to Ontario included CG4 (n = 17), CG6 (n = 
4) and CG7 (n = 2). Each of the 5 remaining clonal groups 
contained only 2 STs with combinations of STs speciﬁ  c to 
Ontario or previously reported in the EWGLI database.
We next did an eBURST comparative analysis of 
the SBT dataset from Ontario with the EWGLI database. 
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Figure 1. Phylogenetic analysis of ﬂ  aA, pilE, asd, mip, mompS, 
proA, and neuA concatenated sequences from the 62 Legionella 
pneumophila serogroup 1 sequence types (STs) identiﬁ  ed  in 
Ontario. The tree was constructed with ClustalW2 (www.ebi.ac.uk/
Tools/clustalw2/index.html) and the neighbor-joining method with 
1,000 bootstrap replicates. Scale bar indicates genetic distances 
between sequences. STs in boldface were detected in outbreaks.RESEARCH
STs detected in Ontario were only clustered in 17 of the 
44 clonal complexes (CC) identiﬁ  ed with the EWGLI da-
tabase. This suggests that >60% of the clonal groups of 
the EWGLI dataset are absent from Ontario. Comparative 
eBURST analysis showed that CG1 is part of CC-B, which 
is the most diversiﬁ  ed clonal complex in the international 
database (59 STs) (Figure 3). In addition to STs included in 
CG1, Ontario isolates ST40 and ST202 grouped in CC-B. 
Philadelphia strain ST36 was predicted to be the founder 
(BC = 91%) of this clonal complex. The high number of 
STs clustered in CC-B (12 STs) suggests that strains be-
longing to this group are evolving in Ontario (Figure 2).
Isolates from CG11 grouped within a CC comprising 
the highest number of EWGLI isolates (n = 490). The pre-
dicted founder of this clonal complex is ST1 and despite its 
high number of isolates, it comprises only 35 STs. Simi-
larly, Ontario CG11 (n = 33) contained only 2 STs which 
suggests that strains belonging to these clonal groups have 
limited genetic variability.
Isolates from CG4 (n = 17) grouped with 2 North 
American clinical strains ST276 and ST289 in CC-A (Fig-
ure 3). Another clonal complex of interest was CC-C ac-
counting for 16 STs (Figure 3). This complex included iso-
lates grouped in CG2 and CG8 as well as 7 STs that were 
not identiﬁ  ed in Ontario. Single isolates ST45, ST109, and 
ST230 from the Ontario dataset also grouped in CC-C. 
Finally, CC-D of the comparative eBURST analysis was 
identical to CG6 (Figure 2).
Temporal Trends of Lp1 Culture-conﬁ  rmed 
Legionellosis in Ontario
During 1978–2007, differences could be observed in 
the distribution of speciﬁ  c STs, clonal complexes and phy-
logroups. During 1981–1994, ST1 strains were regularly 
isolated (n = 29) with case numbers ranging from 0 to 5 
(peaking in 1983) (Figure 4, panel A). During this time pe-
riod, ST1 caused 3 outbreaks and a signiﬁ  cant increase in 
ST1 occurrence was observed (incidence rate ratio [IRR] 
15.37, 95% conﬁ  dence interval [CI] 3.67–64.43, p<0.001). 
In contrast, after 1994, prevalence of ST1 isolates decreased 
markedly (IRR 0.07, CI 0.02–0.27, p<0.001). On average, 
from 1978 through 2007, we observed a signiﬁ  cant de-
crease of 9% per year of ST1 strains in Ontario (p<0.001). 
From 1995 through 2007, only 2 legionellosis ST1 culture-
conﬁ  rmed cases were reported.
In contrast, other STs have emerged in the past 20 
years. ST47 was detected 3 times during 2003–2006. This 
450  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 16, No. 3, March 2010
Figure 2. Dendrogram created by the unweighted pair group method 
with arithmetic mean method based on the 62 allelic proﬁ  les  of 
194 Legionella pneumophila serogroup 1 isolates. Clonal groups 
(CGs) identiﬁ  ed by eBURST (http://eBURST.mlst.net) are indicated 
with solid lines, and STs included in CGs are in boldface. Ontario 
STs included in clonal complexes (CC) identiﬁ  ed by comparative 
eBURST analysis with the European Working Group for Legionella 
Infections database are indicated with dashed lines. The 3 major 
clusters are indicated on the right of the ﬁ  gure with bold lines. The 
number of strains isolated in Ontario is indicated below CG. Scale 
bar indicates linkage distances.
Figure 3. Representation of Legionella pneumophila serogroup 1 
clonal complexes (CC) A, B, C, D obtained by comparative eBURST 
(http://eBURST.mlst.net) analysis between the Ontario collection 
and the European Working Group for Legionella Infections 
database. Each circle represents a single sequence type (ST). Size 
of the circle is proportional to the number of isolates. Dark circles 
represent predicted founder of each CC. Labels in boldface indicate 
STs found in both datasets, regular black characters indicate STs 
absent from the Ontario collection, light gray characters indicate 
STs exclusively found in Ontario. Solid lines represent single-locus 
variants.L. pneumophila Serogroup I Clones, Canada
strain was not isolated before 2003 in Ontario and it cor-
responds to the ST of the Lorraine strain. This emerging 
strain is highly prevalent in France where it was reported 
as the cause of 2 major outbreaks (11). Two other emerg-
ing strains that are unique to Ontario are ST211 and ST222 
(Figure 4, panel B). ST211 was ﬁ  rst isolated in 1989 ac-
counting for 12.5% of clinical isolates. It was regularly iso-
lated from 1990 through 2006, and sporadic cases peaked 
in 1999 (23.1%). ST222 was ﬁ  rst reported in 1999, and the 
prevalence of this strain has signiﬁ  cantly increased (IRR 
1.30 per year, CI 1.12–1.53, p<0.001). Excluding outbreak 
isolates, ST222 accounted for 11.1% to 15.4% of clinical 
isolates in 1999, 2000, 2006, and 2007.
At the clonal complex level, some groups of strains 
have recently emerged in the province of Ontario. Ontario 
strains of CC-A were not detected in Ontario before 1992 
and oscillated from 10% to 25% from 1998 through 2007 
(Figure 5, panel A). This observation is consistent with 
the emergence of ST222, which is a major contributor of 
this clonal complex. Chronological evolution of Ontario 
isolates belonging to CC-C is also noteworthy because it 
appears to be an emerging clonal complex (Figure 5, panel 
B). From 1985 through 1988, the maximum incidence of 
isolates from this clonal complex was 15.4%. CC-C iso-
lates were not reported in 1989 and 1995, but the incidence 
of CC-C isolates gradually increased from 1998 until 2007 
(when it peaked at 37.5%).
Geographic Distribution of Lp1 Clinical 
Strains Isolated in Ontario
The geographic distribution of some individual STs, 
clonal complexes and phylogenetic clusters was not ho-
mogenous. With geographic ratios between 37.5% and 
100%, the 7 STs that caused >10 clinical cases were all 
prevalent in the Toronto OHR. ST1 was widely distrib-
uted: South West, Central South, Central East, East, and 
Toronto OHRs. ST37 was found in all OHRs except the 
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Figure 4. Prevalence of Legionella pneumophila serogroup 
1 sequence type 1 (ST1) (A) and ST211 (B) endemic strains in 
Ontario. Black bar sections indicate proportion of strains from 
isolated cases and white bar sections indicate proportion of isolates 
from outbreaks.
Figure 5. Incidence of Ontario Legionella pneumophila serogroup 
1 isolates from clonal complexes (CC) A and C. CC-A (A) and 
CC-C (B) were identiﬁ   ed by eBURST (http://eBURST.mlst.net) 
comparative analysis using the Ontario and the European Working 
Group for Legionella Infections international databases. Black bar 
sections indicate proportion of strains isolated during sporadic 
cases. White bar sections indicate proportion of outbreak isolates.RESEARCH
East OHR. ST62 was also homogeneously distributed in 
all OHRs with the exception of the North OHR. In con-
trast, distributions of ST36 and ST42 were not homog-
enous because they were only identiﬁ  ed in the Central 
South, Central West, East, and Toronto OHRs. Distri-
bution of ST211 was limited to the Toronto OHR. From 
1978 through 2006, ST211 was identiﬁ  ed 8 times in the 
same hospital. Excluding suspected linked cases, ST211 
was exclusively detected 7 times in the Toronto OHR. 
Despite their recent emergence in 1999, ST222 strains 
were reported in multiple OHRs, including South West, 
Central West, Toronto, and East.
Comparative eBURST analysis between Ontario and 
EWGLI datasets grouped Ontario single isolates ST208 (n 
= 2) with ST257. ST257 was identiﬁ  ed in a clinical case 
of legionellosis from New Hampshire, USA. This small 
clonal complex may be geographically restricted to east-
ern North America. Similarly, geographic distribution of 
CC-A (CG4, ST276, and ST289) was restricted to eastern 
North America. ST276 and ST289 were only reported in 
the states of New York and Connecticut (23). With the ex-
ception of the North OHR, strains belonging to CC-B were 
reported in all OHRs, although a high prevalence of CC-B 
isolates were identiﬁ  ed in the Toronto OHR (63.2%). With-
out signiﬁ  cant geographic prevalence, CC-C isolates were 
identiﬁ  ed in all OHRs. CC-D comprised STs only reported 
in Ontario (Figure 3).
Geographic distributions of Ontario major phylo-
genetic groups were analyzed by mapping average rates 
of culture-conﬁ  rmed Lp1 cases according to OHRs from 
1990 through 2007 (Figure 6). Rates of clusters based 
on sequence-based types and phylogroups appeared to 
be partially dependent on geographic location. As ex-
pected from our distribution analyses of individual 
STs and clonal complexes, the Toronto OHR was more 
likely to have legionellosis cases caused by cluster I/III 
(0.062/100,000 persons/year) and cluster II (0.08/100,000 
persons/year) than all other OHRs. With rates ranging 
from 0.02/100,000 person years for the North OHR to 
0.08/100,000 person-years for the Toronto OHR, isolates 
from cluster II were unevenly reported in all OHRs. In 
contrast, legionellosis caused by cluster I/III were not 
identiﬁ  ed in the North OHR and the rate for the Central 
OHR was only 0.01/100,000 person-years, which is 3.3× 
less than the rate reported for cluster II.
Discussion
This report represents the ﬁ  rst large-scale population-
based SBT analysis of Lp1 clinical isolates within North 
America over a 30-year period. Sixty-two STs were iden-
tiﬁ  ed among the isolates of the Ontario collection, which 
reﬂ  ects a high degree of genetic diversity of Lp1 clinical 
isolates. Forty-one STs were unique to Ontario. Thus, the 
population of clinical Lp1 of this province consists of a 
combination of widely distributed and local isolates.
Although most sporadic cases were caused by isolates 
with a unique ST, some STs, like ST1, were found to be 
responsible for sporadic cases and outbreaks cases. This 
ﬁ  nding is in agreement with the recent identiﬁ  cation of the 
Paris strain in sporadic and outbreak cases (24). Moreover, 
we have identiﬁ   ed additional clones, speciﬁ  cally  ST37, 
ST211, ST222, and ST226, which were also detected in 
sporadic and outbreaks cases. Although some small clonal 
groups such as CG2 exclusively comprised sporadic cases, 
our comparative analysis found no speciﬁ  c correlation be-
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Figure 6. Geographic distribution of phylogenetic clusters II and 
I/III from 1990 through 2007. Rates are cases of infection with 
Legionella pneumophilia serogroup 1 clones per 100,000 persons 
per year. The province of Ontario was divided into 7 health regions 
(OHRs) with populations ranging from ≈0.5 to 2 million persons: 
Toronto, South West (SW), Central South (CS), Central West (CW), 
Central East (CE), East, and North.L. pneumophila Serogroup I Clones, Canada
tween clonal complexes or phylogenetic clusters and abil-
ity to cause sporadic or outbreak cases.
A notable ﬁ  nding of our study is the high proportion 
of ST1 isolates identiﬁ  ed, which supports the hypothesis 
that some speciﬁ  c Lp1 clones have gained widespread dis-
semination. This hypothesis was proposed after analyses of 
protein polymorphism and pulsed-ﬁ  eld gel electrophoresis 
showed similar patterns from isolates distributed world-
wide (25,26). Recently, the Paris strain was suggested to 
be one of these worldwide distributed strains because it has 
been identiﬁ  ed in many European countries in patients and 
environmental samples (24,27). In France, the Paris strain 
was identiﬁ  ed in 12.2% of culture-conﬁ  rmed cases from 
1998 through 2002, and it was shown to be the most preva-
lent endemic strain (28). Our study suggests that the no-
tion of worldwide distributed strains could be broadened to 
include other sequence types such as ST36 or ST37. These 
2 STs have been reported in European countries for clini-
cal and environmental isolates and comprised 16% of STs 
from culture-conﬁ  rmed cases in Ontario.
In previous studies, the clinical predominance and 
large distribution of ST1 suggested that it is a stable clone, 
well adapted to environmental survival or to host infec-
tion (28,29). Surprisingly, although ST1 was identiﬁ  ed in 
16.5% of the culture-conﬁ  rmed cases of legionellosis over 
the past 30 years, our study also shows that the incidence of 
ST1 strains has decreased dramatically during the past 12 
years. Because clonal analysis suggests that ST1 presents a 
limited genetic variability in our geographic area, we can 
hypothesize that its ability to colonize the environment or 
to be isolated by culture or its virulence might have been 
impaired in the recent years. In contrast, endemic clonal 
groups and clinical strains like ST211 have emerged in our 
geographic area in the past 15 years. A surveillance study 
recently reported a new endemic Lorraine strain (ST47) 
emerged in France (11). ST47 was only recovered 3 times 
over 30 years in Ontario, but CC-C, comprising ST47, is 
an emerging clonal complex in Ontario. Our analysis sug-
gests that, globally, ST1 strains are being replaced by other 
emerging strains or clonal complexes.
Geographic distribution analysis of culture-conﬁ  rmed 
population rates suggests that strains from cluster II are 
largely distributed in Ontario, whereas clusters I/III were 
mostly reported in the OHRs in close proximity to Lake 
Ontario. This ﬁ  nding could reﬂ  ect differences in ecologic 
niches (either combined with degree of adaption of organ-
isms to cause human disease or not). Some endemic emerg-
ing STs and clonal groups are exclusively detected in On-
tario, in eastern North America, or in both. In the United 
States, the census regions with highest incidence rates for 
legionellosis are East North central and Middle Atlantic, at 
the proximity of the Great Lakes (30). Legionella species 
are abundant in surface waters and the Great Lakes ecosys-
tem might represent an ideal ecologic niche for these bacte-
ria. This hypothesis is in agreement with the identiﬁ  cation 
of clonal complexes comprising isolates exclusively origi-
nating from eastern North America. This ﬁ  nding contrasts 
with ﬁ  ndings of a recent population structure analysis of L. 
pneumophila that used allelic proﬁ  les from the EWGLI da-
tabase that could not identify eBURST groups containing 
proﬁ  les originating from a single geographic area (22).
In conclusion, we showed that the population of clini-
cal Lp1 in the province of Ontario is a combination of 
worldwide distributed and local strains. Our population of 
isolates might represent more severe cases as human re-
spiratory samples are more frequently taken from patients 
requiring hospitalization, but the decreased prevalence of 
some clones and the emergence of local group of isolates 
suggest that the population of Lp1 has evolved or adapt-
ed to its environment during the past 30 years. Further 
research is required to explain the changing incidence of 
these STs and to investigate the ﬁ  tness of emerging strains 
or clonal groups. Outcomes of this research will be helpful 
to improve surveillance programs for legionellosis as well 
as to ensure adequacy of clinical testing procedures with 
circulating strains.
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